A Review of Exogenous Factors Implicated in the Induction of Cutaneous Melanoma
Main Article Content
Keywords
Cutaneous melanoma, Melanoma, Exogenous factors
Abstract
Melanoma is an increasingly pervasive form of malignant skin cancer. Cases of cutaneous melanoma are on the rise across ages and global populations, with incidence increasing significantly for both men and women. Accordingly, the identification of modifiable behaviors is of paramount concern. Previous reviews have focused on specific risk factors (e.g. UVR, pollution, diet, hormonal supplementation) to the near exclusion of other contributory factors. This review strives to report an inclusive range of exogenous variables linked to cutaneous melanoma incidence. In this review, we examine the various contributions of exogenous factors linked to the induction of cutaneous melanoma. Factors for consideration include but are not limited to: long-wave Ultraviolet A (UVA), short-wave Ultraviolet B (UVB), hormonal supplementation, diet, smoking, alcohol, vitamin supplementation, ionizing radiation, pollution, and chemical exposure.
References
1. US Department of Health and Human Services. The Surgeon General's Call to Action to Prevent Skin Cancer. Washington (DC): Office of the Surgeon General (US); 2014. Available from: https://www.ncbi.nlm.nih.gov/books/NBK247172/
2. IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. (1970, January 1). SOLAR AND ULTRAVIOLET RADIATION. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK304366/.
3. D'Orazio, J., Jarrett, S., Amaro-Ortiz, A., & Scott, T. (2013). UV radiation and the skin. International journal of molecular sciences, 14(6), 12222–12248. https://doi.org/10.3390/ijms140612222
4. Jhappan, C., Noonan, F. & Merlino, G. Ultraviolet radiation and cutaneous malignant melanoma. Oncogene 22, 3099–3112 (2003). https://doi.org/10.1038/sj.onc.1206450
5. Sample, A., & He, Y. Y. (2018). Mechanisms and prevention of UV-induced melanoma. Photodermatology, photoimmunology & photomedicine, 34(1), 13–24. https://doi.org/10.1111/phpp.12329
6. Watson, M., Holman, D. M., & Maguire-Eisen, M. (2016, August). Ultraviolet Radiation Exposure and Its Impact on Skin Cancer Risk. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036351/.
7. Kripke, M. L. (2013, June 21). Impact of Ozone Depletion on Skin Cancers. Retrieved from https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1524-4725.1988.tb03589.x
8. Fabo, E. C. D., Noonan, F. P., Fears, T., & Merlino, G. (2004, September 15). Ultraviolet B but not Ultraviolet A Radiation Initiates Melanoma. Retrieved from https://cancerres.aacrjournals.org/content/64/18/6372.
9. Noonan, F. P., Zaidi, M. R., Wolnicka-Glubisz, A., Anver, M. R., Bahn, J., Wielgus, A., … Fabo, E. C. D. (2012, June 6). Melanoma induction by ultraviolet A but not ultraviolet B radiation requires melanin pigment. Retrieved from https://www.nature.com/articles/ncomms1893.
10. von Thaler, A.-K., Kamenisch, Y., & Berneburg, M. (2010, February). The role of ultraviolet radiation in melanomagenesis. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/20067521.
11. Wang, S. Q., Setlow, R., Berwick, M., Polsky, D., Marghoob, A. A., Kopf, A. W., & Bart, R. S. (2001, May). Ultraviolet A and melanoma: a review. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/11312434.
12. Bruls WA, Slaper H, van der Leun JC, Berrens L. Transmission of human epidermis and stratum corneum as a function of thickness in the ultraviolet and visible wavelengths. Photochemistry and Photobiology. 1984 Oct;40(4):485-494. DOI: 10.1111/j.1751-1097.1984.tb04622.x.
13. Craig, S., Earnshaw, C. H., & Virós, A. (2018, March 5). Ultraviolet light and melanoma. Retrieved from https://onlinelibrary.wiley.com/doi/full/10.1002/path.5039.
14. Viros, A., Sanchez-Laorden, B., Pedersen, M., Furney, S. J., Rae, J., Hogan, K., … Marais, R. (2014). Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53. Nature, 511(7510), 478–482. doi: 10.1038/nature13298
15. Mulliken, J. S., Russak, J. E., & Rigel, D. S. (2012). The Effect of Sunscreen on Melanoma Risk. Dermatologic Clinics, 30(3), 369–376. doi: 10.1016/j.det.2012.04.002
16. Dennis, L. K., Vanbeek, M. J., Beane Freeman, L. E., Smith, B. J., Dawson, D. V., & Coughlin, J. A. (2008). Sunburns and risk of cutaneous melanoma: does age matter? A comprehensive meta-analysis. Annals of epidemiology, 18(8), 614–627. https://doi.org/10.1016/j.annepidem.2008.04.006
17. Holman, D. M., Ding, H., Freeman, M. B., & Shoemaker, M. L. (2019, May 17). Association Between Sun Protection Behaviors and Sunburn Among U.S. Older Adults. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/31100136
18. Davies, H., Bignell, G., Cox, C. et al. Mutations of the BRAF gene in human cancer. Nature 417, 949–954 (2002). https://doi.org/10.1038/nature00766
19. Leslie P. Lund, Graham S. Timmins, Melanoma, long wavelength ultraviolet and sunscreens: Controversies and potential resolutions, Pharmacology & Therapeutics, Volume 114, Issue 2, 2007, Pages 198-207, ISSN 0163-7258, https://doi.org/10.1016/j.pharmthera.2007.01.007.
20. Cleaver, J. E., & Crowley, E. (2002, April 1). UV damage, DNA repair and skin carcinogenesis. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/11897551/.
21. Ullrich, S. E. (2005). Mechanisms underlying UV-induced immune suppression. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 571(1-2), 185–205. doi: 10.1016/j.mrfmmm.2004.06.059
22. Kamenisch, Y., Ivanova, I., Drexler, K., & Berneburg, M. (2018, June 28). UVA, metabolism and melanoma: UVA makes melanoma hungry for metastasis. Retrieved from https://onlinelibrary.wiley.com/doi/10.1111/exd.13561.
23. Khan, A. Q., Travers, J., & Kemp, M. G. (2018, January 1). Roles of UVA radiation and DNA damage responses in melanoma pathogenesis. Retrieved from https://indiana.pure.elsevier.com/en/publications/roles-of-uva-radiation-and-dna-damage-responses-in-melanoma-patho.
24. Lim, H. W., Naylor, M., Hönigsmann, H., Gilchrest, B. A., Cooper, K., Morison, W., … Scherschun, L. (2003, May 19). American Academy of Dermatology Consensus Conference on UVA protection of sunscreens: Summary and recommendations: Washington, DC, Feb 4, 2000. Retrieved from https://www.sciencedirect.com/science/article/abs/pii/S0190962201458762#aep-article-footnote-id1.
25. Dulon, M., Weichenthal, M., Blettner, M., Breitbart, M., Hetzer, M., Greinert, R., … Breitbart, E. W. (2002, November). Sun exposure and number of nevi in 5- to 6-year-old European children. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/12507670.
26. Wolf P; Quehenberger, F; Müllegger, R; Stranz, B; Kerl, H
27. Melanoma Research: August 1998 - p 370-378
28. Silva, E. S. D., Tavares, R., Paulitsch, F. D. S., & Zhang, L. (2018). Use of sunscreen and risk of melanoma and non-melanoma skin cancer: a systematic review and meta-analysis. European Journal of Dermatology, 28(2), 186–201. doi: 10.1684/ejd.2018.3251
29. Volkovova, K., Bilanicova, D., Bartonova, A., Letašiová, S., & Dusinska, M. (2012). Associations between environmental factors and incidence of cutaneous melanoma. Review. Environmental Health, 11(Suppl 1). doi: 10.1186/1476-069x-11-s1-s12
30. Autier, P., Doré, J.-F., Eggermont, A. M., & Coebergh, J. W. (2011). Epidemiological evidence that UVA radiation is involved in the genesis of cutaneous melanoma. Current Opinion in Oncology, 23(2), 189–196. doi: 10.1097/cco.0b013e3283436e5d
31. Moan, J., Baturaite, Z., Porojnicu, A. C., Dahlback, A., & Juzeniene, A. (2011, October 11). UVA, UVB and incidence of cutaneous malignant melanoma in Norway and Sweden. Retrieved from https://pubs.rsc.org/en/content/articlelanding/2012/PP/C1PP05215B#!divAbstract.
32. Hery, C., Tryggvadottir, L., Sigurdsson, T., Olafsdottir, E., Sigurgeirsson, B., Jonasson, J. G., … Autier, P. (2010). A Melanoma Epidemic in Iceland: Possible Influence of Sunbed Use. American Journal of Epidemiology, 172(7), 762–767. doi: 10.1093/aje/kwq238
33. Zhang, M., Qureshi, A. A., Geller, A. C., Frazier, L., Hunter, D. J., & Han, J. (2012, May 10). Use of tanning beds and incidence of skin cancer. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383111/#B7.
34. IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. (1970, January 1). SOLAR AND ULTRAVIOLET RADIATION. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK304366/.
35. Boniol, M., Autier, P., Boyle, P., & Gandini, S. (2012, July 24). Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. Retrieved from https://www.bmj.com/content/345/bmj.e4757.
36. Levine, J. A., Sorace, M., Spencer, J., & Siegel, D. M. (2005, December). The indoor UV tanning industry: a review of skin cancer risk, health benefit claims, and regulation. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/16310065.
37. Moehrle, M., Soballa, M. and Korn, M. (2003), UV exposure in cars. Photodermatology, Photoimmunology & Photomedicine, 19: 175-181. doi:10.1034/j.1600-0781.2003.00031.x
38. Wachler, B. S. B. (2016, July 1). Levels of UV-A Light Protection in Automobile Windshields and Side Windows. Retrieved from https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2522190.
39. Paulson, K. G., Iyer, J. G., & Nghiem, P. (2011, July). Asymmetric lateral distribution of melanoma and Merkel cell carcinoma in the United States. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117975/.
40. Butler, S. T., & Fosko, S. W. (2010). Increased prevalence of left-sided skin cancers. Journal of the American Academy of Dermatology, 63(6), 1006–1010. doi: 10.1016/j.jaad.2009.11.032
41. Goldstein, A. M., & Tucker, M. A. (2013, April). Dysplastic nevi and melanoma. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616416/.
42. Palamaras. (2013). Atypical mole. SpringerReference. doi: 10.1007/springerreference_40348 panel, A. links open overlay, & Publisher Summary This chapter discusses the characteristics. (2008, December 17). Principles of Nonionizing Radiation. Retrieved from https://www.sciencedirect.com/science/article/pii/B9780815511755500455.
43. Schärer, O. D. (2013, October 1). Nucleotide excision repair in eukaryotes. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783044/.
44. McMeniman, E. K., Duffy, D. L., Jagirdar, K., Lee, K. J., Peach, E., McInerney-Leo, A. M., … Sturm, R. A. (2019, December 3). The interplay of sun-damage and genetic risk in Australian multiple and single primary melanoma cases and controls. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/31794051.
45. Ching, J. A., & Gould, L. (2012). Giant scalp melanoma: a case report and review of the literature. Eplasty, 12, e51.
46. Anna, B., Blazej, Z., Jacqueline, G., Andrew, C. J., Jeffrey, R., & Andrzej, S. (2007). Mechanism of UV-related carcinogenesis and its contribution to nevi/melanoma. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2564815/.
47. Bray, H. N., Simpson, M. C., Zahirsha, Z. S., Brinkmeier, J. V., Walen, S. G., Fosko, S. W., & Osazuwa-Peters, N. (Accepted/In press). Head and Neck Melanoma Incidence Trends in the Pediatric, Adolescent, and Young Adult Population of the United States and Canada, 1995-2014. JAMA Otolaryngology - Head and Neck Surgery. https://doi.org/10.1001/jamaoto.2019.2769
48. Gordon, D., Hansson, J., Eloranta, S., Gordon, M., Gillgren, P., & Smedby, K. E. (2017, July 12). Primary tumor sites in relation to ultraviolet radiation exposure and skin visibility correlate with survival in cutaneous melanoma. Retrieved from https://onlinelibrary.wiley.com/doi/10.1002/ijc.30843.
49. Kirkpatrick, C. S., White, E., & Lee, J. A. (1994). Case-Control Study of Malignant Melanoma in Washington State. American Journal of Epidemiology, 139(9), 869–880. doi: 10.1093/oxfordjournals.aje.a117093
50. Silva, J. H., Sá, B. C. de, Avila, A. L. R. de, Landman, G., & Duprat Neto, J. P. (2011). Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma - review article. Retrieved from
51. Friedman, R. J., Farber, M. J., Warycha, M. A., Papathasis, N., Miller, M. K., & Heilman, E. R. (2009). The "dysplastic" nevus. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/19095156.
52. Weinstock, M. A., Stryker, W. S., Stampfer, M. J., Lew, R. A., Willett, W. C., & Sober, A. J. (1991, March 15). Sunlight and dysplastic nevus risk. Results of a clinic-based case-control study. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/2001561.
53. Ellerbroek WC. Oral Contraceptives and Malignant Melanoma. JAMA. 1968;206(3):649–650. doi:10.1001/jama.1968.03150030105038
54. Beral, V., Ramcharan, S., & Faris, R. (1977, December). Malignant melanoma and oral contraceptive use among women in California. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025573/?page=4.
55. National Program of Cancer Registries (NPCR). (2019, March 4). Retrieved from https://www.cdc.gov/cancer/npcr/index.htm
56. Roh, M. R., Eliades, P., Gupta, S., Grant-Kels, J. M., & Tsao, H. (2017). Cutaneous melanoma in women. International journal of women's dermatology, 3(1 Suppl), S11–S15. https://doi.org/10.1016/j.ijwd.2017.02.003
57. Hannaford, P. C., Villard-Mackintosh, L., Vessey, M. P., & Kay, C. R. (1991, March). Oral contraceptives and malignant melanoma. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971847/?page=1.
58. Holly, E. A., Cress, R. D., & Ahn, D. K. (1995, May 15). Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive use. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/7741124.
59. Gandini, S., Iodice, S., Koomen, E., Di Pietro, A., Sera, F., & Caini, S. (2011, November). Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/21620689/.
60. Westerdahl, J., Olsson, H., Måsbäck, A., Ingvar, C., & Jonsson, N. (n.d.). Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors. Retrieved from https://www.nature.com/articles/bjc1996216.
61. Cervenka, I., Mahamat‐Saleh, Y., Savoye, I., Dartois, L., Boutron‐Ruault, M. C., Fournier, A., & Kvaskoff, M. (2018, September 13). Oral contraceptive use and cutaneous melanoma risk: a French prospective cohort study. Retrieved from https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.31644.
62. Cervenka, I., Al Rahmoun, M., Mahamat‐Saleh, Y., Savoye, I., Boutron‐Ruault, M., Fournier, A. and Kvaskoff, M. (2019), Postmenopausal hormone use and cutaneous melanoma risk: A French prospective cohort study. Int. J. Cancer, 145: 1754-1767. doi:10.1002/ijc.32150
63. Koomen, R., E., & Joosse. (2008, August 25). Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case–control study. Retrieved from https://academic.oup.com/annonc/article/20/2/358/164847.
64. Leslie, K. K., & Espey, E. (2005). Oral contraceptives and skin cancer: is there a link? Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/16343023.
65. Lê, M. G., Cabanes, P. A., Desvignes, V., Chanteau, M. F., Mlika, N., & Avril, M. F. (n.d.). Oral contraceptive use and risk of cutaneous malignant melanoma in a case-control study of French women. Retrieved from https://link.springer.com/article/10.1007/BF00124252.
66. Feskanich, D., Hunter, D. J., Willett, W. C., Spiegelman, D., Stampfer, M. J., Speizer, F. E., & Colditz, G. A. (1999, November). Oral contraceptive use and risk of melanoma in premenopausal women. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/10555769.
67. Li, Z., Gu, M., & Cen, Y. (2014, December 15). Age at first birth and melanoma risk: a meta-analysis. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307469/.
68. Botteri, E., Støer, N. C., Sakshaug, S., Graff‐Iversen, S., Vangen, S., Hofvind, S., … Weiderpass, E. (2017, July 19). Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role? Retrieved from https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.30878.
69. Wiedemann, C., Nägele, U., Schramm, G., & Berking, C. (2009, September). Inhibitory effects of progestogens on the estrogen stimulation of melanocytes in vitro. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/19698824?dopt=Abstract.
70. Ramaraj, P., & Cox, J. L. (2014, November 15). In vitro effect of progesterone on human melanoma (BLM) cell growth. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/25550902?dopt=Abstract.
71. Tang, J. Y., Spaunhurst, K. M., Chlebowski, R. T., Wactawski-Wende, J., Keiser, E., Thomas, F., … Stefanick, M. L. (2011, October 5). Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186783/.
72. Snell, R. S., & Bischitz, P. G. (2016, January 7). The Effect of Large Doses of Estrogen and Estrogen and Progesterone on Melanin Pigmentation. Retrieved from https://www.sciencedirect.com/science/article/pii/S0022202X15494308.
73. Plasmeijer, Elsemieke I. et al. (March 2017) The Natural History of Common Melanocytic Nevi: A Systematic Review of Longitudinal Studies in the General Population Journal of Investigative Dermatology, Volume 137, Issue 9, 2017 – 2018
74. Lieberman, R., & Moy, L. (2008, May). Estrogen receptor expression in melasma: results from facial skin of affected patients. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/18505139.
75. Johansson, A. L. V., Andersson, T. M.-L., Plym, A., Ullenhag, G. J., Møller, H., & Lambe, M. (2014, December). Mortality in women with pregnancy-associated malignant melanoma. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/25440438.
76. Smith, M. A., Fine, J. A., Barnhill, R. L., & Berwick, M. (1998, October). Hormonal and reproductive influences and risk of melanoma in women. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/9839729.
77. Zanetti, Roberto, Franceschi, Rosso, Ettore, Colonna, & Stefano. (1990, September 1). Cutaneous Malignant Melanoma in Females: The Role of Hormonal and Reproductive Factors. Retrieved from https://academic.oup.com/ije/article-abstract/19/3/522/760483
78. Rockley, P. F., Trieff, N., Wagner, R. F., & Tyring, S. K. (1994). Nonsunlight Risk Factors For Malignant Melanoma Part I: Chemical Agents, Physical Conditions, And Occupation. International Journal of Dermatology, 33(6), 398–406. doi: 10.1111/j.1365-4362.1994.tb04038.x
79. De Giorgi, V., Gori, A., Grazzini, M., Rossari, S., Scarfì, F., Corciova, S., … Massi, D. (2011, May). Estrogens, estrogen receptors and melanoma. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/21554049?dopt=Abstract.
80. Janik, M. E., Bełkot, K., & Przybyło, M. (2014). Review Is oestrogen an important player in melanoma progression? Współczesna Onkologia, 5, 302–306. doi: 10.5114/wo.2014.43938
81. Marzagalli, M., Montagnani Marelli, M., Casati, L., Fontana, F., Moretti, R. M., & Limonta, P. (2016, October 26). Estrogen Receptor β in Melanoma: From Molecular Insights to Potential Clinical Utility. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080294/.
82. Rivera, A., Nan, H., Li, T., Qureshi, A., & Cho, E. (2016, December). Alcohol Intake and Risk of Incident Melanoma: A Pooled Analysis of Three Prospective Studies in the United States. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137801/.
83. Yen, H., Dhana, A., Okhovat, J.-P., Qureshi, A., Keum, N., & Cho, E. (2017, September). Alcohol intake and risk of nonmelanoma skin cancer: a systematic review and dose-response meta-analysis. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/28745396.
84. Millen, A. E., Tucker, M. A., Hartge, P., Halpern, A., Elder, D. E., Holly, E. A., … DuPont Guerry. (2004, June 1). Diet and Melanoma in a Case-Control Study. Retrieved from https://cebp.aacrjournals.org/content/13/6/1042#ref-44.
85. Williams, R. R., Stegens, N. L., & Goldsmith, J. R. (1977). Associations of Cancer Site and Type With Occupation and Industry From the Third National Cancer Survey Interview. JNCI: Journal of the National Cancer Institute, 59(4), 1147–1185. doi: 10.1093/jnci/59.4.1147
86. Holman CD, Armstrong BK, Heenan PJ. Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst 1986 Mar;76(3):403-14 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/3456458
87. Stryker, W. S., Stampfer, M. J., Stein, E. A., Kaplan, L., Louis, T. A., Sober, A., & Willett, W. C. (1990). Diet, Plasma Levels Of Beta-Carotene And Alpha-Tocopherol, And Risk Of Malignant Melanoma. American Journal of Epidemiology, 131(4), 597–611. doi: 10.1093/oxfordjournals.aje.a115544
88. Veierød, M. B., Thelle, D. S., & Laake, P. (1997, May 16). Diet and risk of cutaneous malignant melanoma: a prospective study of 50,757 Norwegian men and women. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/9178814?dopt=Abstract.
89. Osterlind, A., Tucker, M. A., Stone, B. J., & Jensen, O. M. (1988, December 15). The Danish case-control study of cutaneous malignant melanoma. IV. No association with nutritional factors, alcohol, smoking or hair dyes. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/3192325?dopt=Abstract.
90. Seitz, H. K., & Mueller, S. (2015). Alcohol and cancer: an overview with special emphasis on the role of acetaldehyde and cytochrome P450 2E1. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/25427901/.
91. Brooks, P. J., & Theruvathu, J. A. (2005, April). DNA adducts from acetaldehyde: implications for alcohol-related carcinogenesis. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/16054980.
92. De Pergola, G., & Silvestris, F. (2013). Obesity as a major risk factor for cancer. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773450/.
93. Sergentanis, T. N., Antoniadis, A. G., Gogas, H. J., Antonopoulos, C. N., Adami, H.-O., Ekbom, A., & Petridou, E. T. (2013). Obesity and risk of malignant melanoma: A meta-analysis of cohort and case–control studies. European Journal of Cancer, 49(3), 642–657. doi: 10.1016/j.ejca.2012.08.028
94. Greenlee, H., Unger, J. M., Leblanc, M., Ramsey, S., & Hershman, D. L. (2016). Association between Body Mass Index and Cancer Survival in a Pooled Analysis of 22 Clinical Trials. Cancer Epidemiology Biomarkers & Prevention, 26(1), 21–29. doi: 10.1158/1055-9965.epi-15-1336
95. Schneider, G., Kirschner, M. A., Berkowitz, R., & Ertel, N. H. (1979, April). Increased estrogen production in obese men. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/429508.
96. Jacob, L., Freyn, M., Kalder, M., Dinas, K., & Kostev, K. (2018). Impact of tobacco smoking on the risk of developing 25 different cancers in the UK: a retrospective study of 422,010 patients followed for up to 30 years. Oncotarget, 9(25), 17420–17429. doi:10.18632/oncotarget.24724
97. Kessides, M. C., Wheless, L., Hoffman-Bolton, J., Clipp, S., Alani, R. M., & Alberg, A. J. (2011, January). Cigarette smoking and malignant melanoma: a case-control study. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924442/.
98. Freedman, D. M., Sigurdson, A., Doody, M. M., Rao, R. S., & Linet, M. S. (n.d.). Risk of melanoma in relation to smoking, alcohol intake, and other factors in a large occupational cohort. Retrieved from https://link.springer.com/article/10.1023/B:CACO.0000003839.56954.73.
99. Shaw, H. M., & Milton, G. W. (2006, July 17). Smoking and the development of metastases from malignant melanoma. Retrieved from https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.2910280207.
100. Dusingize, J. C., Olsen, C. M., Pandeya, N., Thompson, B. S., Webb, P. M., Green, A. C., … Whiteman, D. C. (2018, January 1). Smoking and cutaneous melanoma: findings from The QSkin Sun and Health cohort study. Retrieved from https://cebp.aacrjournals.org/content/early/2018/05/22/1055-9965.EPI-17-1056.
101. Ombra1, M. N., Paliogiannis, P., Colombino, M., Casula, M., Sini, M. C., Manca, A., … Queirolo, P. (2019, May 21). Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective. Retrieved from https://nutritionandmetabolism.biomedcentral.com/articles/10.1186/s12986-019-0365-4.
102. Wu, H., Reeves, K. W., Qian, J., & Sturgeon, S. R. (1970, January 1). Coffee, tea, and melanoma risk among postmenopausal women.: Semantic Scholar. Retrieved from https://www.semanticscholar.org/paper/Coffee,-tea,-and-melanoma-risk-among-postmenopausal-Wu-Reeves/78cbe763db2650824dd9d15b0de7e072bd7e553f.
103. Kang, S. J., Choi, B. R., Lee, E. K., Kim, S. H., Yi, H. Y., Park, H. R., … Ku, S. K. (2015, October 13). Inhibitory Effect of Dried Pomegranate Concentration Powder on Melanogenesis in B16F10 Melanoma Cells; Involvement of p38 and PKA Signaling Pathways. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26473849?dopt=Abstract.
104. Wu, Y., Jia, L.-L., Zheng, Y.-N., Xu, X.-G., Luo, Y.-J., Wang, B., … Li, Y.-H. (2013, March). Resveratrate protects human skin from damage due to repetitive ultraviolet irradiation. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22221158?dopt=Abstract.
105. Anstey, A. V. (2002, May). Systemic photoprotection with alpha-tocopherol (vitamin E) and beta-carotene. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/12072001?dopt=Abstract.
106. Baccarin, T., Mitjans, M., Lemos-Senna, E., & Vinardell, M. P. (2015, December 25). Protection against oxidative damage in human erythrocytes and preliminary photosafety assessment of Punica granatum seed oil nanoemulsions entrapping polyphenol-rich ethyl acetate fraction. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26407526?dopt=Abstract.
107. Timerman, D., McEnery-Stonelake, M., Joyce, C. J., Nambudiri, V. E., Hodi, F. S., Claus, E. B., … Lin, J. Y. (2017, January 24). Vitamin D deficiency is associated with a worse prognosis in metastatic melanoma. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351676/.
108. Russo, I., Caroppo, F., & Alaibac, M. (2015, July 24). Vitamins and Melanoma. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586774/.
109. Yew, Y. W., Lai, Y. C., & Schwartz, R. A. (2015, November 7). Coffee Consumption and Melanoma: A Systematic Review and Meta-Analysis of Observational Studies. Retrieved from https://link.springer.com/article/10.1007/s40257-015-0165-1.
110. Wang, J., Li, X., & Zhang, D. (2016, June). Coffee consumption and the risk of cutaneous melanoma: a meta-analysis. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26695410?dopt=Abstract.
111. Wu, S., Han, J., Song, F., Cho, E., Gao, X., Hunter, D. J., & Qureshi, A. A. (2015, November). Caffeine Intake, Coffee Consumption, and Risk of Cutaneous Malignant Melanoma. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26172864?dopt=Abstract.
112. Asgari, M. M., Brasky, T. M., & White, E. (2015, December 8). Association of Vitamin A and Carotenoid Intake with Melanoma Risk in a Large Prospective Cohort. Retrieved from https://www.sciencedirect.com/science/article/pii/S0022202X15357924.
113. Setlow, R. B., Grist, E., Thompson, K., & Woodhead, A. D. (1993). Wavelengths effective in induction of malignant melanoma. Proceedings of the National Academy of Sciences, 90(14), 6666–6670. doi: 10.1073/pnas.90.14.6666
114. Austin, D. F., & Reynolds, P. (1997). Investigation of an Excess of Melanoma among Employees of the Lawrence Livermore National Laboratory. American Journal of Epidemiology, 145(6), 524–531. doi: 10.1093/oxfordjournals.aje.a009140
115. Fink, C. A., & Bates, M. N. (2005). Melanoma and Ionizing Radiation: Is There a Causal Relationship? Radiation Research, 164(5), 701–710. doi: 10.1667/rr3447.1
116. Freedman, D. M., Sigurdson, A., Doody, M. M., Rao, R. S., & Linet, M. S. (n.d.). Risk of melanoma in relation to smoking, alcohol intake, and other factors in a large occupational cohort. Retrieved from https://link.springer.com/article/10.1023/B:CACO.0000003839.56954.73.
117. Azizova, T. V., Bannikova, M. V., Grigoryeva, E. S., & Rybkina, V. L. (2018). Risk of malignant skin neoplasms in a cohort of workers occupationally exposed to ionizing radiation at low dose rates. Plos One, 13(10). doi: 10.1371/journal.pone.0205060
118. Larsson, B. S. (1993). Interaction Between Chemicals and Melanin. Pigment Cell Research, 6(3), 127–133. doi: 10.1111/j.1600-0749.1993.tb00591.x
119. Neagu, M., Caruntu, C., Constantin, C., Boda, D., Zurac, S., Spandidos, D. A., & Tsatsakis, A. M. (2016, May). Chemically induced skin carcinogenesis: Updates in experimental models (Review). Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811393/.
120. Baudouin, C., Charveron, M., Tarroux, R., & Gall, Y. (n.d.). Environmental pollutants and skin cancer. Retrieved from https://link.springer.com/article/10.1023/A:1019540316060.
121. Mehlman, M. A. (2006). Causal Relationship from Exposure to Chemicals in Oil Refining and Chemical Industries and Malignant Melanoma. Annals of the New York Academy of Sciences, 1076(1), 822–828. doi: 10.1196/annals.1371.005
122. Jalilian, H., Ziaei, M., Weiderpass, E., Rueegg, C. S., Khosravi, Y., & Kjaerheim, K. (2019). Cancer incidence and mortality among firefighters. International Journal of Cancer, 145(10), 2639–2646. doi: 10.1002/ijc.32199
123. Gallagher, R. P., Lee, T. K., Weber, J.-P., Leblanc, A., Borugian, M., Elwood, J. M., … Spinelli, J. J. (2010, September 24). Polychlorinated biphenyls (PCB), UV radiation, and cutaneous malignant melanoma. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254998/.
124. Bahn, A. K., Rosenwaike, I., Hermann, N., Grover, P., Stellman, J., & O'Leary, K. (1976, August 19). Letter: Melanoma after exposure to PCB's. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/819831.
125. Brown, D. P., & Jones, M. (1981). Mortality and Industrial Hygiene Study of Workers Exposed to Polychlorinated Biphenyls. Archives of Environmental Health: An International Journal, 36(3), 120–129. doi: 10.1080/00039896.1981.10667615
126. Zani, C., Ceretti, E., Covolo, L., & Donato, F. (2017, September). Do polychlorinated biphenyls cause cancer? A systematic review and meta-analysis of epidemiological studies on risk of cutaneous melanoma and non-Hodgkin lymphoma. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/28535466.
127. Purdue, M. P., Hoppin, J. A., Blair, A., Dosemeci, M., & Alavanja, M. C. R. (2007, February 1). Occupational exposure to organochlorine insecticides and cancer incidence in the Agricultural Health Study. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971137/.
128. Dennis, L. K., Lynch, C. F., Sandler, D. P., & Alavanja, M. C. (2010). Pesticide use and cutaneous melanoma in pesticide applicators in the agricultural heath study. Environmental health perspectives, 118(6), 812–817. https://doi.org/10.1289/ehp.0901518
2. IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. (1970, January 1). SOLAR AND ULTRAVIOLET RADIATION. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK304366/.
3. D'Orazio, J., Jarrett, S., Amaro-Ortiz, A., & Scott, T. (2013). UV radiation and the skin. International journal of molecular sciences, 14(6), 12222–12248. https://doi.org/10.3390/ijms140612222
4. Jhappan, C., Noonan, F. & Merlino, G. Ultraviolet radiation and cutaneous malignant melanoma. Oncogene 22, 3099–3112 (2003). https://doi.org/10.1038/sj.onc.1206450
5. Sample, A., & He, Y. Y. (2018). Mechanisms and prevention of UV-induced melanoma. Photodermatology, photoimmunology & photomedicine, 34(1), 13–24. https://doi.org/10.1111/phpp.12329
6. Watson, M., Holman, D. M., & Maguire-Eisen, M. (2016, August). Ultraviolet Radiation Exposure and Its Impact on Skin Cancer Risk. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036351/.
7. Kripke, M. L. (2013, June 21). Impact of Ozone Depletion on Skin Cancers. Retrieved from https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1524-4725.1988.tb03589.x
8. Fabo, E. C. D., Noonan, F. P., Fears, T., & Merlino, G. (2004, September 15). Ultraviolet B but not Ultraviolet A Radiation Initiates Melanoma. Retrieved from https://cancerres.aacrjournals.org/content/64/18/6372.
9. Noonan, F. P., Zaidi, M. R., Wolnicka-Glubisz, A., Anver, M. R., Bahn, J., Wielgus, A., … Fabo, E. C. D. (2012, June 6). Melanoma induction by ultraviolet A but not ultraviolet B radiation requires melanin pigment. Retrieved from https://www.nature.com/articles/ncomms1893.
10. von Thaler, A.-K., Kamenisch, Y., & Berneburg, M. (2010, February). The role of ultraviolet radiation in melanomagenesis. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/20067521.
11. Wang, S. Q., Setlow, R., Berwick, M., Polsky, D., Marghoob, A. A., Kopf, A. W., & Bart, R. S. (2001, May). Ultraviolet A and melanoma: a review. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/11312434.
12. Bruls WA, Slaper H, van der Leun JC, Berrens L. Transmission of human epidermis and stratum corneum as a function of thickness in the ultraviolet and visible wavelengths. Photochemistry and Photobiology. 1984 Oct;40(4):485-494. DOI: 10.1111/j.1751-1097.1984.tb04622.x.
13. Craig, S., Earnshaw, C. H., & Virós, A. (2018, March 5). Ultraviolet light and melanoma. Retrieved from https://onlinelibrary.wiley.com/doi/full/10.1002/path.5039.
14. Viros, A., Sanchez-Laorden, B., Pedersen, M., Furney, S. J., Rae, J., Hogan, K., … Marais, R. (2014). Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53. Nature, 511(7510), 478–482. doi: 10.1038/nature13298
15. Mulliken, J. S., Russak, J. E., & Rigel, D. S. (2012). The Effect of Sunscreen on Melanoma Risk. Dermatologic Clinics, 30(3), 369–376. doi: 10.1016/j.det.2012.04.002
16. Dennis, L. K., Vanbeek, M. J., Beane Freeman, L. E., Smith, B. J., Dawson, D. V., & Coughlin, J. A. (2008). Sunburns and risk of cutaneous melanoma: does age matter? A comprehensive meta-analysis. Annals of epidemiology, 18(8), 614–627. https://doi.org/10.1016/j.annepidem.2008.04.006
17. Holman, D. M., Ding, H., Freeman, M. B., & Shoemaker, M. L. (2019, May 17). Association Between Sun Protection Behaviors and Sunburn Among U.S. Older Adults. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/31100136
18. Davies, H., Bignell, G., Cox, C. et al. Mutations of the BRAF gene in human cancer. Nature 417, 949–954 (2002). https://doi.org/10.1038/nature00766
19. Leslie P. Lund, Graham S. Timmins, Melanoma, long wavelength ultraviolet and sunscreens: Controversies and potential resolutions, Pharmacology & Therapeutics, Volume 114, Issue 2, 2007, Pages 198-207, ISSN 0163-7258, https://doi.org/10.1016/j.pharmthera.2007.01.007.
20. Cleaver, J. E., & Crowley, E. (2002, April 1). UV damage, DNA repair and skin carcinogenesis. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/11897551/.
21. Ullrich, S. E. (2005). Mechanisms underlying UV-induced immune suppression. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 571(1-2), 185–205. doi: 10.1016/j.mrfmmm.2004.06.059
22. Kamenisch, Y., Ivanova, I., Drexler, K., & Berneburg, M. (2018, June 28). UVA, metabolism and melanoma: UVA makes melanoma hungry for metastasis. Retrieved from https://onlinelibrary.wiley.com/doi/10.1111/exd.13561.
23. Khan, A. Q., Travers, J., & Kemp, M. G. (2018, January 1). Roles of UVA radiation and DNA damage responses in melanoma pathogenesis. Retrieved from https://indiana.pure.elsevier.com/en/publications/roles-of-uva-radiation-and-dna-damage-responses-in-melanoma-patho.
24. Lim, H. W., Naylor, M., Hönigsmann, H., Gilchrest, B. A., Cooper, K., Morison, W., … Scherschun, L. (2003, May 19). American Academy of Dermatology Consensus Conference on UVA protection of sunscreens: Summary and recommendations: Washington, DC, Feb 4, 2000. Retrieved from https://www.sciencedirect.com/science/article/abs/pii/S0190962201458762#aep-article-footnote-id1.
25. Dulon, M., Weichenthal, M., Blettner, M., Breitbart, M., Hetzer, M., Greinert, R., … Breitbart, E. W. (2002, November). Sun exposure and number of nevi in 5- to 6-year-old European children. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/12507670.
26. Wolf P; Quehenberger, F; Müllegger, R; Stranz, B; Kerl, H
27. Melanoma Research: August 1998 - p 370-378
28. Silva, E. S. D., Tavares, R., Paulitsch, F. D. S., & Zhang, L. (2018). Use of sunscreen and risk of melanoma and non-melanoma skin cancer: a systematic review and meta-analysis. European Journal of Dermatology, 28(2), 186–201. doi: 10.1684/ejd.2018.3251
29. Volkovova, K., Bilanicova, D., Bartonova, A., Letašiová, S., & Dusinska, M. (2012). Associations between environmental factors and incidence of cutaneous melanoma. Review. Environmental Health, 11(Suppl 1). doi: 10.1186/1476-069x-11-s1-s12
30. Autier, P., Doré, J.-F., Eggermont, A. M., & Coebergh, J. W. (2011). Epidemiological evidence that UVA radiation is involved in the genesis of cutaneous melanoma. Current Opinion in Oncology, 23(2), 189–196. doi: 10.1097/cco.0b013e3283436e5d
31. Moan, J., Baturaite, Z., Porojnicu, A. C., Dahlback, A., & Juzeniene, A. (2011, October 11). UVA, UVB and incidence of cutaneous malignant melanoma in Norway and Sweden. Retrieved from https://pubs.rsc.org/en/content/articlelanding/2012/PP/C1PP05215B#!divAbstract.
32. Hery, C., Tryggvadottir, L., Sigurdsson, T., Olafsdottir, E., Sigurgeirsson, B., Jonasson, J. G., … Autier, P. (2010). A Melanoma Epidemic in Iceland: Possible Influence of Sunbed Use. American Journal of Epidemiology, 172(7), 762–767. doi: 10.1093/aje/kwq238
33. Zhang, M., Qureshi, A. A., Geller, A. C., Frazier, L., Hunter, D. J., & Han, J. (2012, May 10). Use of tanning beds and incidence of skin cancer. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383111/#B7.
34. IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. (1970, January 1). SOLAR AND ULTRAVIOLET RADIATION. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK304366/.
35. Boniol, M., Autier, P., Boyle, P., & Gandini, S. (2012, July 24). Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. Retrieved from https://www.bmj.com/content/345/bmj.e4757.
36. Levine, J. A., Sorace, M., Spencer, J., & Siegel, D. M. (2005, December). The indoor UV tanning industry: a review of skin cancer risk, health benefit claims, and regulation. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/16310065.
37. Moehrle, M., Soballa, M. and Korn, M. (2003), UV exposure in cars. Photodermatology, Photoimmunology & Photomedicine, 19: 175-181. doi:10.1034/j.1600-0781.2003.00031.x
38. Wachler, B. S. B. (2016, July 1). Levels of UV-A Light Protection in Automobile Windshields and Side Windows. Retrieved from https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2522190.
39. Paulson, K. G., Iyer, J. G., & Nghiem, P. (2011, July). Asymmetric lateral distribution of melanoma and Merkel cell carcinoma in the United States. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117975/.
40. Butler, S. T., & Fosko, S. W. (2010). Increased prevalence of left-sided skin cancers. Journal of the American Academy of Dermatology, 63(6), 1006–1010. doi: 10.1016/j.jaad.2009.11.032
41. Goldstein, A. M., & Tucker, M. A. (2013, April). Dysplastic nevi and melanoma. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616416/.
42. Palamaras. (2013). Atypical mole. SpringerReference. doi: 10.1007/springerreference_40348 panel, A. links open overlay, & Publisher Summary This chapter discusses the characteristics. (2008, December 17). Principles of Nonionizing Radiation. Retrieved from https://www.sciencedirect.com/science/article/pii/B9780815511755500455.
43. Schärer, O. D. (2013, October 1). Nucleotide excision repair in eukaryotes. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783044/.
44. McMeniman, E. K., Duffy, D. L., Jagirdar, K., Lee, K. J., Peach, E., McInerney-Leo, A. M., … Sturm, R. A. (2019, December 3). The interplay of sun-damage and genetic risk in Australian multiple and single primary melanoma cases and controls. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/31794051.
45. Ching, J. A., & Gould, L. (2012). Giant scalp melanoma: a case report and review of the literature. Eplasty, 12, e51.
46. Anna, B., Blazej, Z., Jacqueline, G., Andrew, C. J., Jeffrey, R., & Andrzej, S. (2007). Mechanism of UV-related carcinogenesis and its contribution to nevi/melanoma. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2564815/.
47. Bray, H. N., Simpson, M. C., Zahirsha, Z. S., Brinkmeier, J. V., Walen, S. G., Fosko, S. W., & Osazuwa-Peters, N. (Accepted/In press). Head and Neck Melanoma Incidence Trends in the Pediatric, Adolescent, and Young Adult Population of the United States and Canada, 1995-2014. JAMA Otolaryngology - Head and Neck Surgery. https://doi.org/10.1001/jamaoto.2019.2769
48. Gordon, D., Hansson, J., Eloranta, S., Gordon, M., Gillgren, P., & Smedby, K. E. (2017, July 12). Primary tumor sites in relation to ultraviolet radiation exposure and skin visibility correlate with survival in cutaneous melanoma. Retrieved from https://onlinelibrary.wiley.com/doi/10.1002/ijc.30843.
49. Kirkpatrick, C. S., White, E., & Lee, J. A. (1994). Case-Control Study of Malignant Melanoma in Washington State. American Journal of Epidemiology, 139(9), 869–880. doi: 10.1093/oxfordjournals.aje.a117093
50. Silva, J. H., Sá, B. C. de, Avila, A. L. R. de, Landman, G., & Duprat Neto, J. P. (2011). Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma - review article. Retrieved from
51. Friedman, R. J., Farber, M. J., Warycha, M. A., Papathasis, N., Miller, M. K., & Heilman, E. R. (2009). The "dysplastic" nevus. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/19095156.
52. Weinstock, M. A., Stryker, W. S., Stampfer, M. J., Lew, R. A., Willett, W. C., & Sober, A. J. (1991, March 15). Sunlight and dysplastic nevus risk. Results of a clinic-based case-control study. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/2001561.
53. Ellerbroek WC. Oral Contraceptives and Malignant Melanoma. JAMA. 1968;206(3):649–650. doi:10.1001/jama.1968.03150030105038
54. Beral, V., Ramcharan, S., & Faris, R. (1977, December). Malignant melanoma and oral contraceptive use among women in California. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025573/?page=4.
55. National Program of Cancer Registries (NPCR). (2019, March 4). Retrieved from https://www.cdc.gov/cancer/npcr/index.htm
56. Roh, M. R., Eliades, P., Gupta, S., Grant-Kels, J. M., & Tsao, H. (2017). Cutaneous melanoma in women. International journal of women's dermatology, 3(1 Suppl), S11–S15. https://doi.org/10.1016/j.ijwd.2017.02.003
57. Hannaford, P. C., Villard-Mackintosh, L., Vessey, M. P., & Kay, C. R. (1991, March). Oral contraceptives and malignant melanoma. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971847/?page=1.
58. Holly, E. A., Cress, R. D., & Ahn, D. K. (1995, May 15). Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive use. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/7741124.
59. Gandini, S., Iodice, S., Koomen, E., Di Pietro, A., Sera, F., & Caini, S. (2011, November). Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/21620689/.
60. Westerdahl, J., Olsson, H., Måsbäck, A., Ingvar, C., & Jonsson, N. (n.d.). Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors. Retrieved from https://www.nature.com/articles/bjc1996216.
61. Cervenka, I., Mahamat‐Saleh, Y., Savoye, I., Dartois, L., Boutron‐Ruault, M. C., Fournier, A., & Kvaskoff, M. (2018, September 13). Oral contraceptive use and cutaneous melanoma risk: a French prospective cohort study. Retrieved from https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.31644.
62. Cervenka, I., Al Rahmoun, M., Mahamat‐Saleh, Y., Savoye, I., Boutron‐Ruault, M., Fournier, A. and Kvaskoff, M. (2019), Postmenopausal hormone use and cutaneous melanoma risk: A French prospective cohort study. Int. J. Cancer, 145: 1754-1767. doi:10.1002/ijc.32150
63. Koomen, R., E., & Joosse. (2008, August 25). Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case–control study. Retrieved from https://academic.oup.com/annonc/article/20/2/358/164847.
64. Leslie, K. K., & Espey, E. (2005). Oral contraceptives and skin cancer: is there a link? Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/16343023.
65. Lê, M. G., Cabanes, P. A., Desvignes, V., Chanteau, M. F., Mlika, N., & Avril, M. F. (n.d.). Oral contraceptive use and risk of cutaneous malignant melanoma in a case-control study of French women. Retrieved from https://link.springer.com/article/10.1007/BF00124252.
66. Feskanich, D., Hunter, D. J., Willett, W. C., Spiegelman, D., Stampfer, M. J., Speizer, F. E., & Colditz, G. A. (1999, November). Oral contraceptive use and risk of melanoma in premenopausal women. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/10555769.
67. Li, Z., Gu, M., & Cen, Y. (2014, December 15). Age at first birth and melanoma risk: a meta-analysis. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307469/.
68. Botteri, E., Støer, N. C., Sakshaug, S., Graff‐Iversen, S., Vangen, S., Hofvind, S., … Weiderpass, E. (2017, July 19). Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role? Retrieved from https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.30878.
69. Wiedemann, C., Nägele, U., Schramm, G., & Berking, C. (2009, September). Inhibitory effects of progestogens on the estrogen stimulation of melanocytes in vitro. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/19698824?dopt=Abstract.
70. Ramaraj, P., & Cox, J. L. (2014, November 15). In vitro effect of progesterone on human melanoma (BLM) cell growth. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/25550902?dopt=Abstract.
71. Tang, J. Y., Spaunhurst, K. M., Chlebowski, R. T., Wactawski-Wende, J., Keiser, E., Thomas, F., … Stefanick, M. L. (2011, October 5). Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186783/.
72. Snell, R. S., & Bischitz, P. G. (2016, January 7). The Effect of Large Doses of Estrogen and Estrogen and Progesterone on Melanin Pigmentation. Retrieved from https://www.sciencedirect.com/science/article/pii/S0022202X15494308.
73. Plasmeijer, Elsemieke I. et al. (March 2017) The Natural History of Common Melanocytic Nevi: A Systematic Review of Longitudinal Studies in the General Population Journal of Investigative Dermatology, Volume 137, Issue 9, 2017 – 2018
74. Lieberman, R., & Moy, L. (2008, May). Estrogen receptor expression in melasma: results from facial skin of affected patients. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/18505139.
75. Johansson, A. L. V., Andersson, T. M.-L., Plym, A., Ullenhag, G. J., Møller, H., & Lambe, M. (2014, December). Mortality in women with pregnancy-associated malignant melanoma. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/25440438.
76. Smith, M. A., Fine, J. A., Barnhill, R. L., & Berwick, M. (1998, October). Hormonal and reproductive influences and risk of melanoma in women. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/9839729.
77. Zanetti, Roberto, Franceschi, Rosso, Ettore, Colonna, & Stefano. (1990, September 1). Cutaneous Malignant Melanoma in Females: The Role of Hormonal and Reproductive Factors. Retrieved from https://academic.oup.com/ije/article-abstract/19/3/522/760483
78. Rockley, P. F., Trieff, N., Wagner, R. F., & Tyring, S. K. (1994). Nonsunlight Risk Factors For Malignant Melanoma Part I: Chemical Agents, Physical Conditions, And Occupation. International Journal of Dermatology, 33(6), 398–406. doi: 10.1111/j.1365-4362.1994.tb04038.x
79. De Giorgi, V., Gori, A., Grazzini, M., Rossari, S., Scarfì, F., Corciova, S., … Massi, D. (2011, May). Estrogens, estrogen receptors and melanoma. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/21554049?dopt=Abstract.
80. Janik, M. E., Bełkot, K., & Przybyło, M. (2014). Review Is oestrogen an important player in melanoma progression? Współczesna Onkologia, 5, 302–306. doi: 10.5114/wo.2014.43938
81. Marzagalli, M., Montagnani Marelli, M., Casati, L., Fontana, F., Moretti, R. M., & Limonta, P. (2016, October 26). Estrogen Receptor β in Melanoma: From Molecular Insights to Potential Clinical Utility. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080294/.
82. Rivera, A., Nan, H., Li, T., Qureshi, A., & Cho, E. (2016, December). Alcohol Intake and Risk of Incident Melanoma: A Pooled Analysis of Three Prospective Studies in the United States. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137801/.
83. Yen, H., Dhana, A., Okhovat, J.-P., Qureshi, A., Keum, N., & Cho, E. (2017, September). Alcohol intake and risk of nonmelanoma skin cancer: a systematic review and dose-response meta-analysis. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/28745396.
84. Millen, A. E., Tucker, M. A., Hartge, P., Halpern, A., Elder, D. E., Holly, E. A., … DuPont Guerry. (2004, June 1). Diet and Melanoma in a Case-Control Study. Retrieved from https://cebp.aacrjournals.org/content/13/6/1042#ref-44.
85. Williams, R. R., Stegens, N. L., & Goldsmith, J. R. (1977). Associations of Cancer Site and Type With Occupation and Industry From the Third National Cancer Survey Interview. JNCI: Journal of the National Cancer Institute, 59(4), 1147–1185. doi: 10.1093/jnci/59.4.1147
86. Holman CD, Armstrong BK, Heenan PJ. Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst 1986 Mar;76(3):403-14 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/3456458
87. Stryker, W. S., Stampfer, M. J., Stein, E. A., Kaplan, L., Louis, T. A., Sober, A., & Willett, W. C. (1990). Diet, Plasma Levels Of Beta-Carotene And Alpha-Tocopherol, And Risk Of Malignant Melanoma. American Journal of Epidemiology, 131(4), 597–611. doi: 10.1093/oxfordjournals.aje.a115544
88. Veierød, M. B., Thelle, D. S., & Laake, P. (1997, May 16). Diet and risk of cutaneous malignant melanoma: a prospective study of 50,757 Norwegian men and women. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/9178814?dopt=Abstract.
89. Osterlind, A., Tucker, M. A., Stone, B. J., & Jensen, O. M. (1988, December 15). The Danish case-control study of cutaneous malignant melanoma. IV. No association with nutritional factors, alcohol, smoking or hair dyes. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/3192325?dopt=Abstract.
90. Seitz, H. K., & Mueller, S. (2015). Alcohol and cancer: an overview with special emphasis on the role of acetaldehyde and cytochrome P450 2E1. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/25427901/.
91. Brooks, P. J., & Theruvathu, J. A. (2005, April). DNA adducts from acetaldehyde: implications for alcohol-related carcinogenesis. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/16054980.
92. De Pergola, G., & Silvestris, F. (2013). Obesity as a major risk factor for cancer. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773450/.
93. Sergentanis, T. N., Antoniadis, A. G., Gogas, H. J., Antonopoulos, C. N., Adami, H.-O., Ekbom, A., & Petridou, E. T. (2013). Obesity and risk of malignant melanoma: A meta-analysis of cohort and case–control studies. European Journal of Cancer, 49(3), 642–657. doi: 10.1016/j.ejca.2012.08.028
94. Greenlee, H., Unger, J. M., Leblanc, M., Ramsey, S., & Hershman, D. L. (2016). Association between Body Mass Index and Cancer Survival in a Pooled Analysis of 22 Clinical Trials. Cancer Epidemiology Biomarkers & Prevention, 26(1), 21–29. doi: 10.1158/1055-9965.epi-15-1336
95. Schneider, G., Kirschner, M. A., Berkowitz, R., & Ertel, N. H. (1979, April). Increased estrogen production in obese men. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/429508.
96. Jacob, L., Freyn, M., Kalder, M., Dinas, K., & Kostev, K. (2018). Impact of tobacco smoking on the risk of developing 25 different cancers in the UK: a retrospective study of 422,010 patients followed for up to 30 years. Oncotarget, 9(25), 17420–17429. doi:10.18632/oncotarget.24724
97. Kessides, M. C., Wheless, L., Hoffman-Bolton, J., Clipp, S., Alani, R. M., & Alberg, A. J. (2011, January). Cigarette smoking and malignant melanoma: a case-control study. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924442/.
98. Freedman, D. M., Sigurdson, A., Doody, M. M., Rao, R. S., & Linet, M. S. (n.d.). Risk of melanoma in relation to smoking, alcohol intake, and other factors in a large occupational cohort. Retrieved from https://link.springer.com/article/10.1023/B:CACO.0000003839.56954.73.
99. Shaw, H. M., & Milton, G. W. (2006, July 17). Smoking and the development of metastases from malignant melanoma. Retrieved from https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.2910280207.
100. Dusingize, J. C., Olsen, C. M., Pandeya, N., Thompson, B. S., Webb, P. M., Green, A. C., … Whiteman, D. C. (2018, January 1). Smoking and cutaneous melanoma: findings from The QSkin Sun and Health cohort study. Retrieved from https://cebp.aacrjournals.org/content/early/2018/05/22/1055-9965.EPI-17-1056.
101. Ombra1, M. N., Paliogiannis, P., Colombino, M., Casula, M., Sini, M. C., Manca, A., … Queirolo, P. (2019, May 21). Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective. Retrieved from https://nutritionandmetabolism.biomedcentral.com/articles/10.1186/s12986-019-0365-4.
102. Wu, H., Reeves, K. W., Qian, J., & Sturgeon, S. R. (1970, January 1). Coffee, tea, and melanoma risk among postmenopausal women.: Semantic Scholar. Retrieved from https://www.semanticscholar.org/paper/Coffee,-tea,-and-melanoma-risk-among-postmenopausal-Wu-Reeves/78cbe763db2650824dd9d15b0de7e072bd7e553f.
103. Kang, S. J., Choi, B. R., Lee, E. K., Kim, S. H., Yi, H. Y., Park, H. R., … Ku, S. K. (2015, October 13). Inhibitory Effect of Dried Pomegranate Concentration Powder on Melanogenesis in B16F10 Melanoma Cells; Involvement of p38 and PKA Signaling Pathways. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26473849?dopt=Abstract.
104. Wu, Y., Jia, L.-L., Zheng, Y.-N., Xu, X.-G., Luo, Y.-J., Wang, B., … Li, Y.-H. (2013, March). Resveratrate protects human skin from damage due to repetitive ultraviolet irradiation. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22221158?dopt=Abstract.
105. Anstey, A. V. (2002, May). Systemic photoprotection with alpha-tocopherol (vitamin E) and beta-carotene. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/12072001?dopt=Abstract.
106. Baccarin, T., Mitjans, M., Lemos-Senna, E., & Vinardell, M. P. (2015, December 25). Protection against oxidative damage in human erythrocytes and preliminary photosafety assessment of Punica granatum seed oil nanoemulsions entrapping polyphenol-rich ethyl acetate fraction. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26407526?dopt=Abstract.
107. Timerman, D., McEnery-Stonelake, M., Joyce, C. J., Nambudiri, V. E., Hodi, F. S., Claus, E. B., … Lin, J. Y. (2017, January 24). Vitamin D deficiency is associated with a worse prognosis in metastatic melanoma. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351676/.
108. Russo, I., Caroppo, F., & Alaibac, M. (2015, July 24). Vitamins and Melanoma. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586774/.
109. Yew, Y. W., Lai, Y. C., & Schwartz, R. A. (2015, November 7). Coffee Consumption and Melanoma: A Systematic Review and Meta-Analysis of Observational Studies. Retrieved from https://link.springer.com/article/10.1007/s40257-015-0165-1.
110. Wang, J., Li, X., & Zhang, D. (2016, June). Coffee consumption and the risk of cutaneous melanoma: a meta-analysis. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26695410?dopt=Abstract.
111. Wu, S., Han, J., Song, F., Cho, E., Gao, X., Hunter, D. J., & Qureshi, A. A. (2015, November). Caffeine Intake, Coffee Consumption, and Risk of Cutaneous Malignant Melanoma. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26172864?dopt=Abstract.
112. Asgari, M. M., Brasky, T. M., & White, E. (2015, December 8). Association of Vitamin A and Carotenoid Intake with Melanoma Risk in a Large Prospective Cohort. Retrieved from https://www.sciencedirect.com/science/article/pii/S0022202X15357924.
113. Setlow, R. B., Grist, E., Thompson, K., & Woodhead, A. D. (1993). Wavelengths effective in induction of malignant melanoma. Proceedings of the National Academy of Sciences, 90(14), 6666–6670. doi: 10.1073/pnas.90.14.6666
114. Austin, D. F., & Reynolds, P. (1997). Investigation of an Excess of Melanoma among Employees of the Lawrence Livermore National Laboratory. American Journal of Epidemiology, 145(6), 524–531. doi: 10.1093/oxfordjournals.aje.a009140
115. Fink, C. A., & Bates, M. N. (2005). Melanoma and Ionizing Radiation: Is There a Causal Relationship? Radiation Research, 164(5), 701–710. doi: 10.1667/rr3447.1
116. Freedman, D. M., Sigurdson, A., Doody, M. M., Rao, R. S., & Linet, M. S. (n.d.). Risk of melanoma in relation to smoking, alcohol intake, and other factors in a large occupational cohort. Retrieved from https://link.springer.com/article/10.1023/B:CACO.0000003839.56954.73.
117. Azizova, T. V., Bannikova, M. V., Grigoryeva, E. S., & Rybkina, V. L. (2018). Risk of malignant skin neoplasms in a cohort of workers occupationally exposed to ionizing radiation at low dose rates. Plos One, 13(10). doi: 10.1371/journal.pone.0205060
118. Larsson, B. S. (1993). Interaction Between Chemicals and Melanin. Pigment Cell Research, 6(3), 127–133. doi: 10.1111/j.1600-0749.1993.tb00591.x
119. Neagu, M., Caruntu, C., Constantin, C., Boda, D., Zurac, S., Spandidos, D. A., & Tsatsakis, A. M. (2016, May). Chemically induced skin carcinogenesis: Updates in experimental models (Review). Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811393/.
120. Baudouin, C., Charveron, M., Tarroux, R., & Gall, Y. (n.d.). Environmental pollutants and skin cancer. Retrieved from https://link.springer.com/article/10.1023/A:1019540316060.
121. Mehlman, M. A. (2006). Causal Relationship from Exposure to Chemicals in Oil Refining and Chemical Industries and Malignant Melanoma. Annals of the New York Academy of Sciences, 1076(1), 822–828. doi: 10.1196/annals.1371.005
122. Jalilian, H., Ziaei, M., Weiderpass, E., Rueegg, C. S., Khosravi, Y., & Kjaerheim, K. (2019). Cancer incidence and mortality among firefighters. International Journal of Cancer, 145(10), 2639–2646. doi: 10.1002/ijc.32199
123. Gallagher, R. P., Lee, T. K., Weber, J.-P., Leblanc, A., Borugian, M., Elwood, J. M., … Spinelli, J. J. (2010, September 24). Polychlorinated biphenyls (PCB), UV radiation, and cutaneous malignant melanoma. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254998/.
124. Bahn, A. K., Rosenwaike, I., Hermann, N., Grover, P., Stellman, J., & O'Leary, K. (1976, August 19). Letter: Melanoma after exposure to PCB's. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/819831.
125. Brown, D. P., & Jones, M. (1981). Mortality and Industrial Hygiene Study of Workers Exposed to Polychlorinated Biphenyls. Archives of Environmental Health: An International Journal, 36(3), 120–129. doi: 10.1080/00039896.1981.10667615
126. Zani, C., Ceretti, E., Covolo, L., & Donato, F. (2017, September). Do polychlorinated biphenyls cause cancer? A systematic review and meta-analysis of epidemiological studies on risk of cutaneous melanoma and non-Hodgkin lymphoma. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/28535466.
127. Purdue, M. P., Hoppin, J. A., Blair, A., Dosemeci, M., & Alavanja, M. C. R. (2007, February 1). Occupational exposure to organochlorine insecticides and cancer incidence in the Agricultural Health Study. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971137/.
128. Dennis, L. K., Lynch, C. F., Sandler, D. P., & Alavanja, M. C. (2010). Pesticide use and cutaneous melanoma in pesticide applicators in the agricultural heath study. Environmental health perspectives, 118(6), 812–817. https://doi.org/10.1289/ehp.0901518
Article Sidebar
Published
May 8, 2020
Article Details
How to Cite
Hands, J. M., & Moy, L. (2020). A Review of Exogenous Factors Implicated in the Induction of Cutaneous Melanoma. SKIN The Journal of Cutaneous Medicine, 4(3), 200–220. https://doi.org/10.25251/skin.4.3.2
Issue
Section
In-Depth Reviews
This work is licensed under a Creative Commons Attribution 4.0 International License.
All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by the following user license:
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.
Author Biography